Study
Tumor suppressor miR-133a modulates the prostate cancer epigenome by repressing BAZ2A
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001000568 | Other |
Study Description
Our study revealed a new subgroup of prostate tumors defined by the expression of a novel prognostic marker, BAZ2A, and the first time to show the establishment of CIMP via an microRNA-epigenetic interaction in prostate tumors.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00010000646 |
DNA methylation analysis of 35 prostate tumor and 6 normal prostate samples
|
41 |
Who archives the data?
